Weber Christophe Pierre

Weber Christophe Pierre is listed in filings as Director at Boston Scientific Corp. This profile follows SEC Form 4 activity through May 11, 2026, including 8 public disclosures. Recent filings connect the profile to Boston Scientific Corp (BSX) and Takeda Pharmaceutical Co Ltd (TAK). The current snapshot covers public activity from Mar 4, 2026 to May 11, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.